# Eli Lilly raises revenue outlook as weight-loss injections offset Foundayo shortfall

https://mins.news/en/item/120955

- Reuters, 2026-10-29 14:40 UTC
- Economy
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-lifts-revenue-outlook-weight-loss-drug-sales-trims-profit-view-deal-2026-10-29/?link_source=ta_bluesky_link&taid=6ae35ace27f3420001c8de87

> Eli Lilly lifted its full-year revenue forecast and topped third-quarter profit estimates on Thursday. Strong demand for its injectable weight-loss drugs offset a weaker-than-expected launch of its obesity pill, Foundayo, and shares jumped.

## Related coverage

- [Eli Lilly beats estimates, raises sales outlook as Zepbound and Mounjaro demand surges again](https://mins.news/en/item/120697) — CNBC, 2026-10-29